Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Arvinas Inc. (ARVN) PT Lowered to $16 at BTIG
May 2, 2025 5:35 AM EDTBTIG analyst Jeet Mukherjee lowered the price target on Arvinas Inc. (NASDAQ: ARVN) to $16.00 (from $69.00) while maintaining a Buy rating.
The analyst comments "ARVN reported 1Q25 earnings, and together with partner Pfizer (PFE, Not Rated), announced a re-prioritization of vepdegestrant's development... More
